Alimentary Canal

Barium Swallows

Colorectal Cancer

Digestive Oncology

Endocrine Disorders


Triple Helicobacter Pylori Eradication Therapy Guided By Genotypic Resistance Can Be Highly Effective In Seven Days.


Mohith Sharma

Department of Surgery, Jammu & Kashmir, UT, India

Correspondence to Author:  Mohith Sharma


Background: The efficaciousness and pertinence of molecular testing to guide the choice of antibiotics in triple Helicobacter pylori (H. pylori) wipeout regimens haven’t been reportable. we have a tendency to tested a 7-day, makeup resistance-guided triple H. pylori wipeout medical care in a very high-resistance setting. Methods: Consecutive dyspeptic patients with H. pylori infection were prospectively registered. makeup resistances to clarithromycin (23SrRNA mutations) and fluoroquinolones (gyrA mutations) were determined from stomachal diagnostic test specimens employing a commercially obtainable molecular assay (GenoTypeâ HelicoDR). A tailored makeup resistance-guided 7-day triple medical care comprised esomeprazole, Larotid, and either clarithromycin (wild-type 23SrRNA), levofloxacin (23SrRNA mutated/wild-type gyrA) or rifabutin (both 23SrRNA/gyrA mutated). H. pylori wipeout was confirmed by 13C-urea breath check. Results: Of 148 subjects screened, fifty one patients were registered (male/female: 27/24, mean age: fifty.7±11.4 years, treatment-naïve/-experienced: 32/19). The molecular kit was simply enforced, allowing speedy (within twenty four h) and comparatively cheap determination of H. pylori resistance (clarithromycin: forty seven.1%, fluoroquinolones: fifteen.7%, twin clarithromycin/fluoroquinolones: seven.8%). For patients UN agency received clarithromycin-, levofloxacin- and rifabutin-containing triple medical care, the several wipeout rates were 24/27, 20/20, and 2/4 by intention-to-treat (ITT); and 24/24, 19/19 and 2/3 by per-protocol (PP) analysis. Overall wipeout rates were ninety.2% (95% confidence interval [CI] seventy seven.8-96.3%) by ITT and ninety seven.8% (95%CI 87-99.8%) by PP analysis, showing no vital distinction between treatment-naïve and -experienced patients (ITT: eighty seven.5% vs. 94.7%, P=0.64; PP: 96.4% vs. 100%, severally, P=1.00). Conclusions: notwithstanding previous treatment history, a makeup resistance-guided 7-day triple medical care, supported an easy molecular assay, achieved a high H. pylori wipeout rate.

Helicobacter pylori, tailored therapy, 23SrRNA, gyrA, triple Helicobacter pylori eradication therapy.


Mohith Sharma. Triple Helicobacter pylori eradication therapy guided by genotypic resistance can be highly effective in seven days. Japanese Journal of Gastroenterology 2022.

Journal Info

  • Journal Name: Japanese Journal of Gastroenterology
  • Impact Factor: 2.709**
  • ISSN: 2832-4870
  • DOI: 10.52338/jjogastro
  • Short Name: JJOGASTRO
  • Acceptance rate: 55%
  • Volume: 4 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days


  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal


  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility